Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for myocardial reperfusion in STEMI undergoing primary PCI
IRCT20200519047506N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in myocardial infarction (MI) and acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Troponin I, CK-MB and 5 more. Started Jul 2020; status: completed.
02
Drugs
acetylcysteine
03
Conditions
myocardial infarction (MI)acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on IRCT20200519047506N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200519047506N1.